Clinigence Holdings Inc (NUTX)
NASDAQ:NUTX
Want to see NUTX full AI Analyst Report?
Earnings Data
Report Date
Aug 06, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
4.64Last Year’s EPS
-2.95Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call presents a mixed picture: operationally and strategically Nutex demonstrates strong liquidity, improved net income, positive cash flow, active share repurchases, patient satisfaction, and a clear strategy to internalize development and scale population health. However, significant margin pressure and a 21% drop in adjusted EBITDA driven by higher facility costs and timing effects from IDR/arbitration recognition temper the results. Same-hospital revenue growth was minimal and accounts receivable rose, highlighting near-term execution and working capital considerations. Regulatory and arbitration accounting dynamics introduce additional volatility. Overall, positive cash generation and strategic initiatives are balanced by meaningful margin and accounting headwinds.Company Guidance
Revenue Growth
Total revenue of $216.5 million in Q1 2026, up ~2.2% year-over-year (from $211.8M in Q1 2025). Hospital division revenue grew to $207.6M (up 1.8% YoY) and same-hospital revenue was roughly flat (+0.2% YoY).
Net Income Improvement
Net income attributable to Nutex was $46.8 million versus $21.2 million in Q1 2025 — an increase of $25.6 million (approximately +121% year-over-year).
Strong Operating Cash Flow and Liquidity
Net cash provided by operating activities was $75.5 million in Q1 2026, up 48% from $51.0 million in Q1 2025. Cash and cash equivalents grew to $207.3 million as of March 31, 2026, up 11.7% from $185.6 million at year-end 2025.
Share Repurchase Activity
Completed inaugural $25 million share repurchase program retiring ~119,000 shares and initiated a second $25 million repurchase program during the quarter, signaling management confidence in intrinsic value.
Patient Volume and Engagement
Total hospital visits increased to ~49.7K (49,742 reported by CFO), up ~3.1% year-over-year. Same-hospital visits increased modestly (~+0.6%). Patient experience strong: over 2,400 reviews and average Google rating of 4.8/5.
Population Health Momentum
Population Health division revenue increased to $8.9 million in Q1 2026 from $7.8 million in Q1 2025 — ~+14% year-over-year; platform now oversees ~40,000 patients across Medicare Advantage, commercial and Medicaid managed care.
Balance Sheet Deleveraging and Asset Growth
Net long-term debt decreased from $29.2 million at Dec 31, 2025 to $24.3 million at quarter end. Total bank/equipment debt declined modestly (example: $41.3M at Mar 31, 2026 vs $43.5M at Dec 31, 2025).
Strategic Investment in Development and Technology
Board approved direct investment in development/construction of new hospitals (project cost ~$20–30M each; 18–24 month build timeline). Company plans to monetize via sale-leaseback/REIT transactions; ongoing investments in AI/IT and service lines to drive growth and scalability.
IDR / Arbitration Track Record
Company submits ~50–60% of claims through the IDR process, currently prevailing >85% of determinations and collecting >80% of awarded amounts — demonstrating effectiveness of arbitration strategy despite timing volatility.
NUTX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
NUTX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 30, 2026 | $119.20 | $139.57 | +17.09% |
Mar 05, 2026 | $105.34 | $90.28 | -14.30% |
Nov 19, 2025 | $112.19 | $142.34 | +26.87% |
Nov 18, 2025 | $99.20 | $112.19 | +13.09% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Clinigence Holdings Inc (NUTX) report earnings?
Clinigence Holdings Inc (NUTX) is schdueled to report earning on Aug 06, 2026, After Close (Confirmed).
What is Clinigence Holdings Inc (NUTX) earnings time?
Clinigence Holdings Inc (NUTX) earnings time is at Aug 06, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NUTX EPS forecast?
NUTX EPS forecast for the fiscal quarter 2026 (Q2) is 4.64.